Table 1:
Baseline characteristics.
| Patients (n=113) | |
|---|---|
| Sex, male (%) | 80 (71%) |
| Age, years | 64.8 ±14.4 |
| Body mass index, kg/m2 | 26.1 ±6.8 |
| Chronic kidney disease | 36 (32%) |
| Stage | |
| 1 | 2 (5.5%) |
| 2 | 5 (13.9%) |
| 3 | 19 (52.8%) |
| 4 | 4 (11.1%) |
| 5 | 4 (11.1%) |
| 5- Dialysis | 2 (5.5%) |
| Anaemia | 13/110 (11.8%) |
| History of heart failure | 16/110 (11.8%) |
| LVEF§ | 55.2 % ±15.9 |
| High blood pressure | 59/110 (53.6%) |
| Diabetes mellitus | 26/110 (23.6%) |
| Active smocking | 31/105 (29.5%) |
| Dyslipidaemia | 32/110 (29.1%) |
| NSAID | 3 (2.7%) |
| ACE inhibitor/ARB | 62 (56.4%) |
| Diuretics | 27 (24.5%) |
| Haemoglobin£, g/dL | 13.5 ±1.73 |
| Test | |
| None | 33 (29.2%) |
| Coronary angiogram | 51 (45.1%) |
| Coronary angioplasty | 2 (1.8%) |
| Angiography | 25 (22.1%) |
| Peripheral angiogram | 2 (1.8%) |
LVEF: left ventricular ejection fraction; NSAID: non-steroidal anti-inflammatory drug; ACE: angiotensin-converting enzyme; ARB: angiotensin receptor blocker § data available for 67 patients £data available for 95 patients.